Machine Learning-Driven Drug Repurposing for KRAS G12C and KRAS G12D Inhibition
Gianluca Fuschi, J Germain, David Bebensee…·Muhamed Amin
This study uses machine learning to screen FDA-approved compounds for KRAS G12C and G12D inhibition, identifying potential drug candidates for further experimental validation.